Fingolimod (FTY720) supports ADLs in Multiple Sclerosis
Fingolimod (FTY720) supports ADLs in Multiple Sclerosis
Multiple sclerosis patients who took the oral investigational agent fingolimod were better able to maintain activities of daily living over a year than those treated with injected interferon beta-1A, according to a study presented here at CMSC-ACTRIMS.
Patients taking the standard injected therapy interferon beta-1A (Avonex) had more pronounced decline in their ability to perform ADLs based on a patient reported activity scale -- dropping by 0.43 points over 12 months, compared with those on either of two doses of fingolimod, whose scores dropped by just 0.08 and 0.12 points (P<0.05 for both comparisons), Jeffrey Cohen, MD, of the Neurologic Institute of the Cleveland Clinic in Cleveland, Ohio, reported.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1309
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1460 Views
-
Last post by frodo
-
- 0 Replies
- 1525 Views
-
Last post by frodo
-
- 1 Replies
- 1736 Views
-
Last post by frodo
-
- 0 Replies
- 1672 Views
-
Last post by frodo
-
- 0 Replies
- 1138 Views
-
Last post by frodo
-
- 0 Replies
- 1765 Views
-
Last post by NHE
-
- 0 Replies
- 2067 Views
-
Last post by frodo
-
- 0 Replies
- 3503 Views
-
Last post by frodo
-
- 0 Replies
- 1333 Views
-
Last post by frodo